6 research outputs found

    Comparison of Archean and Phanerozoic granulites: Southern India and North American Appalachians

    Get PDF
    Archean granulites at the southern end of the Dharwar craton of India and Phanerozoic granulites in the southern Appalachians of North America share an important characteristic: both show continuous transitions from amphibolite facies rocks to higher grade. This property is highly unusual for granulite terranes, which commonly are bounded by major shears or thrusts. These two terranes thus offer an ideal opportunity to compare petrogenetic models for deep crustal rocks formed in different time periods, which conventional wisdom suggests may have had different thermal profiles. The salient features of the Archean amphibolite-to-granulite transition in southern India have been recently summarized. The observed metamorphic progression reflects increasing temperature and pressure. Conditions for the Phanerozoic amphibolite-to-granulite transition in the southern Appalachians were documented. The following sequence of prograde reactions was observed: kyanite = sillimanite, muscovite = sillimanite + K-feldspar, partial melting of pelites, and hornblende = orthopyroxene + clinopyroxene + garnet. The mineral compositions of low-variance assemblages in mafic and intermediate rocks are almost identical for the two granulite facies assemblages. In light of their different fluid regimes and possible mechanisms for heat flow augmentation, it seems surprising that these Archean and Phanerozoic granulite terranes were apparently metamorphosed under such similar conditions of pressure and temperature. Comparison with other terrains containing continuous amphibolite-to-granulite facies transitions will be necessary before this problem can be addressed

    Gene expression profiling reveals potential prognostic biomarkers associated with the progression of heart failure

    Get PDF
    Abstract BACKGROUND: Heart failure (HF) is the most common cause of morbidity and mortality in developed countries. Here, we identify biologically relevant transcripts that are significantly altered in the early phase of myocardial infarction and are associated with the development of post-myocardial infarction HF. METHODS: We collected peripheral blood samples from patients with ST-segment elevation myocardial infarction (STEMI): n = 111 and n = 41 patients from the study and validation groups, respectively. Control groups comprised patients with a stable coronary artery disease and without a history of myocardial infarction. Based on plasma NT-proBNP level and left ventricular ejection fraction parameters the STEMI patients were divided into HF and non-HF groups. Microarrays were used to analyze mRNA levels in peripheral blood mononuclear cells (PBMCs) isolated from the study group at four time points and control group. Microarray results were validated by RT-qPCR using whole blood RNA from the validation group. RESULTS: Samples from the first three time points (admission, discharge, and 1 month after AMI) were compared with the samples from the same patients collected 6 months after AMI (stable phase) and with the control group. The greatest differences in transcriptional profiles were observed on admission and they gradually stabilized during the follow-up. We have also identified a set of genes the expression of which on the first day of STEMI differed significantly between patients who developed HF after 6 months of observation and those who did not. RNASE1, FMN1, and JDP2 were selected for further analysis and their early up-regulation was confirmed in HF patients from both the study and validation groups. Significant correlations were found between expression levels of these biomarkers and clinical parameters. The receiver operating characteristic (ROC) curves indicated a good prognostic value of the genes chosen. CONCLUSIONS: This study demonstrates an altered gene expression profile in PBMCs during acute myocardial infarction and through the follow-up. The identified gene expression changes at the early phase of STEMI that differentiated the patients who developed HF from those who did not could serve as a convenient tool contributing to the prognosis of heart failure

    SLAVERY: ANNUAL BIBLIOGRAPHICAL SUPPLEMENT (2005)

    No full text

    2013 ACCF/AHA Guideline for the Management of Heart Failure

    No full text
    corecore